Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
AppTech Payments | APCX | Apr 17, 2025 | 0.34 | +1.04 |
Aprea Therapeutics | APRE | Apr 17, 2025 | 1.50 | -2.39 |
AptarGroup | ATR | Apr 17, 2025 | 143.83 | -0.81 |
Aptevo Therapeutics | APVO | Apr 17, 2025 | 0.86 | -3.53 |
Aptiv | APTV | Apr 17, 2025 | 51.71 | +1.97 |
Aptorum Group A | APM | Apr 17, 2025 | 0.83 | -9.14 |
Aptose Biosciences | APTO | Apr 17, 2025 | 1.71 | 0.00 |
Apyx Medical | APYX | Apr 17, 2025 | 0.97 | +4.84 |
Aqua Metals | AQMS | Apr 17, 2025 | 1.56 | -1.27 |
AquaBounty Technologies | AQB | Apr 17, 2025 | 0.65 | 0.00 |
Aquaron Acquisition | AQU | Apr 17, 2025 | 11.68 | 0.00 |
Aquaron Acquisition Units | AQUNU | Apr 17, 2025 | 11.90 | 0.00 |
Aquestive Therapeutics | AQST | Apr 17, 2025 | 2.51 | +0.40 |
Aramark | ARMK | Apr 17, 2025 | 32.17 | +0.59 |
ARB IOT Group | ARBB | Apr 17, 2025 | 0.76 | +6.00 |
Arbe Robotics | ARBE | Apr 17, 2025 | 1.08 | +2.86 |
Arbor Realty Trust | ABR | Apr 17, 2025 | 11.03 | +2.80 |
Arbor Realty Trust D Pref | ABR-D | Apr 17, 2025 | 17.10 | +0.06 |
Arbor Realty Trust E Pref | ABR-E | Apr 17, 2025 | 16.69 | +0.24 |
Arbor Realty Trust F Pref | ABR-F | Apr 17, 2025 | 20.40 | -2.16 |
Arbutus Biopharma | ABUS | Apr 17, 2025 | 3.15 | +2.94 |
Arcadia Biosciences | RKDA | Apr 17, 2025 | 2.95 | -6.62 |
ArcBest | ARCB | Apr 17, 2025 | 60.99 | +4.06 |
Arcellx | ACLX | Apr 17, 2025 | 62.02 | +2.19 |
Arcelor Mittal ADR | MT | Apr 17, 2025 | 27.23 | +1.15 |
Arch Capital F Pref | ACGLO | Apr 17, 2025 | 20.14 | -0.49 |
Arch Capital G | ACGLN | Apr 17, 2025 | 16.75 | -0.42 |
Arch Capital Group | ACGL | Apr 17, 2025 | 92.57 | +0.21 |
Archer Aviation A | ACHR | Apr 17, 2025 | 7.23 | +2.55 |
Archer Daniels Midland | ADM | Apr 17, 2025 | 47.82 | +3.66 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.